AstraZeneca weighs $400B Bristol Myers merger
AstraZeneca has held talks with Bristol Myers Squibb about a potential merger that would create one of the world’s largest drugmakers with a combined market value of nearly $400 billion, according to an Aug. 2 report from Financial Times. The companies have discussed a tie-up in recent months, though the talks could still be delayed […] The post AstraZeneca weighs $400B Bristol Myers merger appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.